Asunto(s)
Conservación de los Recursos Naturales , Actividades Recreativas , Salud Pública , Opinión Pública , Política Pública , Conservación de los Recursos Naturales/economía , Conservación de los Recursos Naturales/historia , Conservación de los Recursos Naturales/legislación & jurisprudencia , Ejercicio Físico/fisiología , Ejercicio Físico/psicología , Agricultura Forestal/economía , Agricultura Forestal/educación , Agricultura Forestal/historia , Historia del Siglo XX , Humanos , Italia/etnología , Actividades Recreativas/economía , Actividades Recreativas/psicología , Historia Natural/educación , Historia Natural/historia , Salud Pública/economía , Salud Pública/educación , Salud Pública/historia , Opinión Pública/historia , Política Pública/economía , Política Pública/historia , Política Pública/legislación & jurisprudencia , Bienestar Social/economía , Bienestar Social/etnología , Bienestar Social/historia , AguaRESUMEN
The ability of the laryngeal mask airway, tracheal tube and facemask to provide a leak free seal in a clinical setting was assessed by measuring the minimal fresh gas flows needed in a closed circle system during spontaneous ventilation on 60 subjects. The fresh gas flow was reduced until no spillage occurred from the pop-off valve. This fresh gas flow was taken to represent the sum of gas uptake by the subject and gas leakage from the circuit. The median fresh gas flow after 20 minutes was 350 ml.min-1 in the laryngeal mask airway group, 350 ml.min-1 in the tracheal tube group and 450 ml.min-1 in the facemask group. The fresh gas flow required for the facemask group was significantly higher than that for the laryngeal mask airway or tracheal tube groups (p < 0.01). There was no significant difference between the fresh gas flows required for the tracheal tube and laryngeal mask airway group. We conclude that the laryngeal mask airway provides as good a gas tight seal as a tracheal tube in this context and would be of benefit in reducing anaesthetic gas pollution.
Asunto(s)
Contaminantes Ocupacionales del Aire , Anestesia por Circuito Cerrado , Anestésicos por Inhalación , Máscaras Laríngeas , Adulto , Femenino , Humanos , Intubación Intratraqueal , Masculino , Máscaras , Persona de Mediana Edad , QuirófanosRESUMEN
Overdose with the sympathomimetic agent phenylpropanolamine (PPA) may cause arrhythmias and myocardial injury in humans. To study the mechanism of these toxic effects, unanesthetized rats (6 animals per group) were given single intraperitoneal doses of 1, 2, 4, 8, 16, or 32 mg/kg PPA. Increases in blood pressure, measured by tail cuff, were dose related and comparable to increases reported in patients with PPA toxicity. Animals were killed at 24 hr and light microscopic examination showed diffuse, dose-related myocardial necrosis. Histology scores (a measure of severity of necrosis) in groups receiving 8, 16, and 32 mg/kg PPA were 1.4 +/- 0.5, 1.8 +/- 1.0, and 2.3 +/- 0.4, respectively, and were all significantly greater than the histology score of control animals (0.2 +/- 0.3, p less than 0.01). The observed lesion was similar in appearance to the myocardial necrosis produced by large doses of catecholamines or sympathomimetic agents in rats. In summary, single doses of PPA caused myocardial necrosis in rats at doses comparable to those causing toxicity in humans. Myocardial necrosis may contribute to the cardiac toxicity of PPA overdose.